X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9880) 9880
Publication (581) 581
Book Review (206) 206
Book Chapter (153) 153
Conference Proceeding (26) 26
Dissertation (15) 15
Magazine Article (6) 6
Data Set (3) 3
Journal / eJournal (3) 3
Book / eBook (2) 2
Paper (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6537) 6537
index medicus (5206) 5206
antiplatelet therapy (3751) 3751
male (3481) 3481
female (3051) 3051
clopidogrel (2884) 2884
aspirin (2798) 2798
cardiac & cardiovascular systems (2734) 2734
platelet aggregation inhibitors - therapeutic use (2652) 2652
aged (2462) 2462
middle aged (2435) 2435
ticlopidine - analogs & derivatives (2026) 2026
percutaneous coronary intervention (1833) 1833
treatment outcome (1727) 1727
risk factors (1588) 1588
pharmacology & pharmacy (1523) 1523
peripheral vascular disease (1506) 1506
antiplatelet (1478) 1478
thrombosis (1470) 1470
platelet aggregation inhibitors - adverse effects (1356) 1356
platelet aggregation inhibitors - administration & dosage (1353) 1353
dual antiplatelet therapy (1311) 1311
ticlopidine - therapeutic use (1216) 1216
myocardial-infarction (1210) 1210
hematology (1191) 1191
platelet aggregation - drug effects (1170) 1170
acute coronary syndromes (1162) 1162
platelet aggregation inhibitors - pharmacology (1155) 1155
aspirin - therapeutic use (1122) 1122
stroke (1120) 1120
drug therapy, combination (1109) 1109
animals (1036) 1036
risk (978) 978
stents (972) 972
anticoagulants (969) 969
time factors (906) 906
drug-eluting stents (902) 902
antiplatelet agents (879) 879
prevention (876) 876
drug therapy (847) 847
blood platelets - drug effects (846) 846
adult (844) 844
cardiology (835) 835
care and treatment (816) 816
aged, 80 and over (780) 780
ticlopidine - administration & dosage (764) 764
abridged index medicus (761) 761
acute coronary syndrome (761) 761
acute myocardial-infarction (759) 759
cardiovascular (743) 743
coronary heart disease (730) 730
mortality (724) 724
antiplatelet drugs (713) 713
blood platelets (702) 702
surgery (701) 701
aspirin - administration & dosage (699) 699
therapy (696) 696
analysis (685) 685
prospective studies (677) 677
hemorrhage - chemically induced (662) 662
prasugrel (662) 662
medicine, general & internal (660) 660
anticoagulants - therapeutic use (635) 635
heart attacks (634) 634
aggregation (630) 630
cardiac patients (626) 626
retrospective studies (620) 620
bleeding (613) 613
medicine & public health (610) 610
cardiovascular diseases (608) 608
intervention (604) 604
ticlopidine - adverse effects (603) 603
ticagrelor (586) 586
trial (586) 586
cardiovascular disease (584) 584
myocardial infarction (576) 576
platelets (574) 574
risk assessment (570) 570
aspirin - adverse effects (560) 560
double-blind (558) 558
stent (558) 558
warfarin (541) 541
stent thrombosis (540) 540
dose-response relationship, drug (537) 537
artery-disease (533) 533
acute coronary syndrome - drug therapy (532) 532
management (517) 517
inhibition (516) 516
secondary prevention (515) 515
clinical neurology (499) 499
coronary artery disease (495) 495
thrombosis - prevention & control (491) 491
research (489) 489
patients (482) 482
follow-up studies (481) 481
platelet aggregation (478) 478
implantation (477) 477
anticoagulation (476) 476
outcomes (474) 474
fibrinolytic agents - therapeutic use (469) 469
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9510) 9510
German (138) 138
French (116) 116
Japanese (86) 86
Russian (65) 65
Spanish (62) 62
Polish (18) 18
Korean (15) 15
Czech (11) 11
Italian (8) 8
Portuguese (8) 8
Chinese (6) 6
Slovenian (4) 4
Slovak (3) 3
Croatian (2) 2
Hungarian (2) 2
Serbian (2) 2
Turkish (2) 2
Arabic (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 11, pp. 1251 - 1263
Multidrug therapy increases the risk for drug–drug interactions. Clopidogrel, a prodrug, requires hepatic cytochrome P450 (CYP) metabolic activation to produce... 
Cardiovascular | Internal Medicine | clopidogrel | proton pump inhibitors | omeprazole | drug interactions | atorvastatin | statins | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR EVENTS | STATIN INTERACTION | HEALTHY-SUBJECTS | STENT PLACEMENT | ACUTE CORONARY SYNDROMES | PROTON-PUMP INHIBITORS | CONCOMITANT USE | DUAL ANTIPLATELET THERAPY | PLATELET INHIBITION | ST-SEGMENT ELEVATION | Proton Pump Inhibitors - adverse effects | Ticlopidine - therapeutic use | Humans | Proton Pump Inhibitors - therapeutic use | Ticlopidine - analogs & derivatives | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Polypharmacy | Proton Pump Inhibitors - pharmacokinetics | Coronary Disease - metabolism | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Drug Interactions - physiology | Ticlopidine - adverse effects | Coronary Disease - drug therapy | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Clinical Trials as Topic - methods | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Omeprazole | Complications and side effects | Medical colleges | Metabolites | Drug interactions | Cardiac patients | Cytochrome P-450 | Cardiology | Coronary heart disease | Adenosine triphosphatase | Cardiovascular agents | Heart attacks | Drug therapy | Rodents | Coronary vessels | Statins
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 8, pp. 777 - 786
Background The currently recommended duration of dual antiplatelet therapy (DAPT) in drug-eluting stent (DES) recipients is 12 months to reduce the risk of... 
double antiplatelet duration | percutaneous coronary angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | THROMBOSIS | BARE-METAL STENTS | FOLLOW-UP | RISK | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | POOLED ANALYSIS | CLINICAL-OUTCOMES | PLATELET REACTIVITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Middle East | Early Termination of Clinical Trials | Coronary Restenosis - diagnosis | Coronary Artery Disease - physiopathology | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Everolimus | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Coronary Vessels - pathology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Europe | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Vessels - surgery | Aged | Percutaneous Coronary Intervention - adverse effects | Aspirin
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2008, Volume 52, Issue 14, pp. 1134 - 1140
Journal Article
MEDICINE, ISSN 0025-7974, 11/2017, Volume 96, Issue 47, p. e8878
Background: Even if drug-eluting stents (DES) showed beneficial effects in patients with coronary artery diseases (CADs), limitations have been observed with... 
major adverse cardiac events | EFFICACY | durable polymer drug-eluting stents | SAFETY | THROMBOSIS | randomized controlled trials | CLINICAL FOLLOW-UP | MEDICINE, GENERAL & INTERNAL | DUAL ANTIPLATELET THERAPY | REDUCTION | stent thrombosis | OUTCOMES | INTERVENTION | biodegradable polymer drug-eluting stents | CORONARY-ARTERY-DISEASE | DURATION | long-term
Journal Article
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2011, Volume 57, Issue 11, pp. 1264 - 1270
Journal Article